When TRAF6 is overexpressed, it confers at least three known cancer hallmarks, including maintenance of proliferative signaling, resistance to cell death, and induction of angiogenesis [42], in pancreatic [44] and breast [45] cancers. This evidence concerns the gene TRAF6 and cancer.